Quadrant Capital Group’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-31
| Closed | -$606 | – | 1482 |
|
|
2025
Q1 | $606 | Hold |
31
| – | – | ﹤0.01% | 2636 |
|
|
2024
Q4 | $769 | Sell |
31
-88
| -74% | -$2.18K | ﹤0.01% | 2615 |
|
|
2024
Q3 | $2.92K | Hold |
119
| – | – | ﹤0.01% | 2433 |
|
|
2024
Q2 | $2.79K | Sell |
119
-930
| -89% | -$21.8K | ﹤0.01% | 2422 |
|
|
2024
Q1 | $34.7K | Sell |
1,049
-153
| -13% | -$5.06K | ﹤0.01% | 1585 |
|
|
2023
Q4 | $32.7K | Sell |
1,202
-128
| -10% | -$3.48K | ﹤0.01% | 1592 |
|
|
2023
Q3 | $32K | Buy |
+1,330
| New | +$32K | ﹤0.01% | 1482 |
|
|
2023
Q1 | – | Sell |
-44
| Closed | -$1.72K | – | 2721 |
|
|
2022
Q4 | $1.72K | Hold |
44
| – | – | ﹤0.01% | 2452 |
|
|
2022
Q3 | $2K | Hold |
44
| – | – | ﹤0.01% | 2336 |
|
|
2022
Q2 | $2K | Buy |
+44
| New | +$2K | ﹤0.01% | 2181 |
|
|
2021
Q4 | – | Sell |
-97
| Closed | -$8K | – | 2512 |
|
|
2021
Q3 | $8K | Buy |
+97
| New | +$8K | ﹤0.01% | 1690 |
|